文献速递腹部CT

可切除胰尾胰腺导管腺癌中胰腺外器官侵犯的预后意义

Prognostic implication of extra-pancreatic organ invasion in resectable pancreas ductal adenocarcinoma in the pancreas tail.
PubMed 文献 · Eur J Radiol · 2024-09-02

回顾性纳入2014至2020年一家三级机构158例接受 upfront 手术的可切除胰尾胰腺导管腺癌患者,评估术前胰腺方案CT与术后病理所见的胰腺外器官侵犯对切缘状态和生存的影响;结果显示胰腺外器官侵犯与切缘阳性及无复发生存均无独立关联,作者认为不应将其视为高风险因素。

要点

  • CT或病理所见的胰腺外器官侵犯与切缘阳性无显著关联(CT p=0.92,病理 p=0.99)。
  • CT或病理所见的胰腺外器官侵犯均非无复发生存的独立预测因素(CT p=0.42,病理 p=0.64)。
  • CT可疑转移性淋巴结是无复发生存的独立预测因素(HR 2.05,95%CI 1.08-3.9,p=0.03)。

核心结论

  • 在可切除胰尾胰腺导管腺癌接受根治性切除的患者中,胰腺外器官侵犯对病理切缘状态和无复发生存无独立影响,作者认为不应将其视为高风险因素。

研究设计与样本

  • 回顾性研究纳入2014至2020年一家三级机构接受 upfront 手术的可切除胰尾胰腺导管腺癌患者158例(平均年龄65岁±8.8标准差,93例男性)。
  • 术前采用胰腺方案CT评估肿瘤大小、胰腺周围肿瘤浸润、可疑转移性淋巴结和胰腺外器官侵犯。
  • 采用logistic回归评估CT或术后病理检测的胰腺外器官侵犯对病理切缘状态的影响,采用多变量Cox比例风险模型(临床-CT模型和临床-病理模型)分析对无复发生存的影响。

诊断标准与关键数值

  • CT检测的胰腺外器官侵犯与切缘阳性无关联(p=0.92),病理检测的胰腺外器官侵犯与切缘阳性无关联(p=0.99)。
  • CT检测的胰腺外器官侵犯与无复发生存无独立相关(p=0.42),病理检测的胰腺外器官侵犯与无复发生存无独立相关(p=0.64)。
  • 临床-CT模型中,CT可疑转移性淋巴结是无复发生存的独立预测因素(HR 2.05,95%CI 1.08-3.9,p=0.03)。
  • 临床-病理模型中,病理T分期是无复发生存的独立预测因素(T2 vs 参照:HR 2.97,95%CI 1.39-6.35,p=0.005;T3 vs 参照:HR 3.78,95%CI 1.64-8.76,p=0.002)。
  • 临床-病理模型中,辅助治疗与无复发生存相关(HR 0.62,95%CI 0.42-0.92,p=0.02)。

临床应用与阅片要点

  • 原文结论认为胰腺外器官侵犯不应被视为可切除胰尾胰腺导管腺癌的高风险因素。
  • 原文未据此给出关于阅片或报告的具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the prognostic significance of extra-pancreatic organ invasion in patients with resectable pancreatic ductal adenocarcinoma (PDAC) in the pancreas tail.

MATERIALS & METHODS: This retrospective study included patients with resectable PDAC in the pancreas tail who received upfront surgery between 2014 and 2020 at a tertiary institution. Preoperative pancreas protocol computed tomography (CT) scans evaluated tumor size, peripancreatic tumor infiltration, suspicious metastatic lymph nodes, and extra-pancreatic organ invasion. The influence of extra-pancreatic organ invasion, detected by CT or postoperative pathology, on pathologic resection margin status was evaluated using logistic regression. The impact on recurrence-free survival (RFS) was analyzed using multivariable Cox proportional hazard models (clinical-CT and clinical-pathologic).

RESULTS: The study included 158 patients (mean age, 65 years ± 8.8 standard deviation; 93 men). Extra-pancreatic organ invasion identified by either CT (p = 0.92) or pathology (p = 0.99) was not associated with a positive resection margin. Neither CT (p = 0.42) nor pathological (p = 0.64) extra-pancreatic organ invasion independently correlated with RFS. Independent predictors for RFS included suspicious metastatic lymph node (hazard ratio [HR], 2.05; 95 % confidence interval [CI], 1.08-3.9; p = 0.03) on CT in the clinical-CT model, pathological T stage (HR, 2.97; 95 % confidence interval [CI], 1.39-6.35; p = 0.005 for T2 and HR, 3.78; 95 % CI, 1.64-8.76; p = 0.002 for T3) and adjuvant therapy (HR, 0.62; 95 % confidence interval [CI], 0.42-0.92; p = 0.02) in the clinical-pathologic model.

CONCLUSION: Extra-pancreatic organ invasion does not independently influence pathologic resection margin status and RFS in patients with resectable PDAC in the pancreas tail after curative-intent resection; therefore, it should not be considered a high-risk factor.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ji Jang H, Soo Lee S, Baek S, et al. Prognostic implication of extra-pancreatic organ invasion in resectable pancreas ductal adenocarcinoma in the pancreas tail. Eur J Radiol. 2024. PMID: 39241306. doi:10.1016/j.ejrad.2024.111715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。